Understanding the impact of immune-mediated selection on lung cancer evolution

被引:0
|
作者
Rachel Rosenthal
Charles Swanton
Nicholas McGranahan
机构
[1] The Francis Crick Institute,Cancer Evolution and Genome Instability Laboratory
[2] University College London Cancer Institute,Cancer Research UK Lung Cancer Centre of Excellence
[3] University College London Hospitals,Department of Medical Oncology
[4] University College London,Cancer Genome Evolution Research Group, University College London Cancer Institute
来源
British Journal of Cancer | 2021年 / 124卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Understanding how a tumour evolves and avoids immune recognition is paramount to improving cancer immunotherapy and patient outcome. Here we examine our recent integration of multi-region genomic, transcriptomic, epigenomic, pathology, and clinical data, highlight the need for a systematic examination of immune escape mechanisms, and discuss implications for immunotherapy approaches.
引用
收藏
页码:1615 / 1617
页数:2
相关论文
共 50 条
  • [21] New insights into the understanding of MHC associations with immune-mediated disorders
    Caillat-Zucman, S.
    HLA, 2017, 89 (01) : 3 - 13
  • [22] Impact of moderate wine consumption on immune-mediated diseases
    Di Lorenzo, Chiara
    Restani, Patrizia
    Antoce, Arina Oana
    Romano, Raquel
    Fradera, Ursula
    Teissedre, Pierre-Louis
    Ruf, Jean-Claude
    Bani, Corinne
    Mercogliano, Francesca
    Araujo, Marcos
    Kosti, Rena I.
    OENO ONE, 2024, 58 (03)
  • [23] Impact of climate change on immune-mediated inflammatory diseases
    Beydon, Maxime
    Roeser, Anais
    Costedoat-Chalumeau, Nathalie
    de Sainte-Marie, Benjamin
    Nguyen, Yann
    Club Greenternist, Club
    REVUE DE MEDECINE INTERNE, 2024, 45 (12): : 739 - 743
  • [24] Aggravating Impact of Nanoparticles on Immune-Mediated Pulmonary Inflammation
    Inoue, Ken-Ichiro
    Takano, Hirohisa
    THESCIENTIFICWORLDJOURNAL, 2011, 11 : 382 - 390
  • [25] Immune-mediated tumor evolution: Nanog links the emergence of a stem like cancer cell state and immune evasion
    Mao, Chih-Ping
    Wu, T. C.
    Song, Kwon-Ho
    Kim, Tae Woo
    ONCOIMMUNOLOGY, 2014, 3 (07):
  • [26] Nitrofurantoin-induced immune-mediated lung and liver disease
    Schattner, A
    Von der Walde, J
    Kozak, N
    Sokolovskaya, N
    Knobler, H
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1999, 317 (05): : 336 - 340
  • [27] Nitrofurantoin-induced immune-mediated lung and liver disease
    Milic, Rade
    Plavec, Goran
    Tufegdzic, Ivana
    Tomic, Ilija
    Sarac, Sanja
    Loncarevic, Olivera
    VOJNOSANITETSKI PREGLED, 2012, 69 (06) : 536 - 540
  • [28] Effects of amphetamine on immune-mediated lung inflammatory response in rats
    Ligeiro-Oliveira, AP
    de Araújo, AMF
    Lazzarini, R
    Silva, ZL
    De Nucci, G
    Muscará, MN
    de Lima, WT
    Palermo-Neto, J
    NEUROIMMUNOMODULATION, 2004, 11 (03) : 181 - 190
  • [29] Haemolytic anaemia after lung transplantation: an immune-mediated phenomenon?
    Riechsteiner, G
    Speich, R
    Schanz, U
    Russi, EW
    Weder, W
    Boehler, A
    SWISS MEDICAL WEEKLY, 2003, 133 (9-10) : 143 - 147
  • [30] Effects of amphetamine on immune-mediated lung inflamatory responses in rats
    Palermo-Neto, J.
    Oliveira, A. P. L.
    Araujo, A. M. F.
    Lazzarini, R.
    Silva, Z. L.
    De Nucci, G.
    Muscara, M. N.
    Lima, W. T.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 94 - 94